Research in the Velenosi Lab is at the intersection of pharmacology, analytical chemistry, and bioinformatics to study metabolite and lipid biomarkers with a focus on:

​

1) Developing computational methods for improving mass spectrometry-based metabolomics, lipidomics and stable isotope tracing, and

2) Applying these techniques to cutting-edge cancer models, including patient derived xenografts, to identify and characterize metabolic biomarkers and therapeutic targets that can improve therapies for cancer patients.